Maliarov, Anton https://orcid.org/0000-0001-6839-557X
Newman, Nicholas
Sabouret, Pierre
Al-Shakfa, Fidaa
Chergui, Sami
Lavoie, Frédéric
Article History
Received: 28 July 2022
Accepted: 12 December 2022
First Online: 20 February 2023
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. The study (14.150) was approved by the Institutional Review Board of the hospital (CER of the CHUM, Montreal, Canada). The Clinical trial number is NCT03145493 (the approval was dated by 3 October 2014). Informed consent was obtained from all individual participants included in the study. The signing of a consent form agreeing to participate in the study as well as adhering to a systematically documented follow-up protocol was obtained.
: The authors affirm that human research participants provided informed consent for the publication of the study, tables, and images in figures.
: The following authors: A.M., N.N., P.S., F.A.S., S.C., F.L. have no relevant financial or non-financial interests to disclose.